|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 1:451-465, 2002.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
250 proteins. To identify all the components of human cilia, we have begun a comprehensive proteomic analysis of isolated ciliary axonemes. Analysis by two-dimensional (2-D) PAGE resulted in a highly reproducible 2-D map consisting of over 240 well resolved components. Individual protein spots were digested with trypsin and sequenced using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Peptide matches were obtained to 38 potential ciliary proteins by this approach. To identify ciliary components not resolved by 2-D PAGE, axonemal proteins were separated on a one-dimensional gel. The gel lane was divided into 45 individual slices, each of which was analyzed by LC/MS/MS. This experiment resulted in peptide matches to an additional 110 proteins. In a third approach, preparations of isolated axonemes were digested with Lys-C, and the resulting peptides were analyzed directly by LC/MS/MS or by multidimensional LC/MS/MS, leading to the identification of a further 66 proteins. Each of the four approaches resulted in the identification of a subset of the proteins present. In total, sequence data were obtained on over 1400 peptides, and over 200 potential axonemal proteins were identified. Peptide matches were also obtained to over 200 human expressed sequence tags. As an approach to validate the mass spectrometry results, additional studies examined the expression of several identified proteins (annexin I, sperm protein Sp17, retinitis pigmentosa protein RP1) in cilia or ciliated cells. These studies represent the first proteomic analysis of the human ciliary axoneme and have identified many potentially novel components of this complex organelle.
The structure of respiratory tract cilia has been the subject of many previous microscopic studies. These studies have demonstrated the 9 + 2 arrangement of microtubules, the inner and outer dynein arms, the radial spokes, and other features common to all motile cilia. However, much of our understanding of cilia structure and function has been derived by analogy to model systems, such as Chlamydomonas and Paramecium. Although these models have provided a wealth of information, to understand the structure and regulation of human cilia it is clear that complementary studies of human material are required.
An important step toward a complete understanding of ciliary function is the identification of all the protein components that comprise the ciliary axoneme (a ciliary proteome). Early studies of Chlamydomonas suggested that an axoneme may be composed of over 250 individual proteins (5, 6), and a number of these have been identified and studied. However, whereas the sequencing of the human genome has allowed the identification of homologs of these Chlamydomonas proteins, biochemical evidence is still necessary to demonstrate their axonemal nature in human cilia. Further, it is likely that human cilia will contain important novel proteins not found in simpler model systems.
Although the difficulty of obtaining human cilia has limited previous studies, recent advances in cell culture techniques allow ciliated cell differentiation of human airway epithelial cells to occur in vitro (7, 8), providing a reliable source of material. Coupled with the improvements in sensitivity and throughput of mass spectrometry, the identification of the ciliary proteome is now feasible. Because it is not yet clear which separation technique, if any, is optimal, we employed both one- and two-dimensional gel electrophoresis, as well as multidimensional liquid chromatography (9), in this initial characterization of the ciliary axoneme.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
5080% of the culture surface was ciliated.
Isolation of Cilia
Cilia were isolated as described previously (1012). Briefly, heavily ciliated cultures were washed with cold phosphate-buffered saline to remove mucus and cell debris. Deciliation buffer (12) was added to the surface, and the culture was rocked gently for 1 min. The supernatant was collected, and the procedure was repeated. The two washings were pooled, and after pelleting debris at 1000 x g, the ciliary axonemes were collected by centrifugation at 16,000 x g and frozen at -80 °C. During the course of these studies, an additional wash step was included in some preparations to further reduce contamination of the axonemes. Ciliary pellets were resuspended gently in 30 mM Hepes (pH 7.3), 1 mM EGTA, 0.1 mM EDTA, 25 mM NaCl, 5 mM MgSO4, 1 mM dithiothreitol, and 1% volume of protease inhibitor mixture (Sigma). Triton X-100 was added (0.5%) to the suspension, and the axonemes were incubated for 15 min on ice, followed by centrifugation. Protein concentrations were estimated using the BCA reagent (Pierce).
2-D Gel Electrophoresis and Analysis
First-dimension isoelectric focusing was carried out using 18-cm NL Immobiline DryStrips (pH 310; Amersham Biosciences) on an IPGphor (Amersham Biosciences) according to the manufacturers instructions. Axonemal pellets (4070 µg) were resuspended directly in sample buffer and focused at 20 volts for 12 h; at 100, 250, 500, 1000, and 2500 volts for 1 h each; and at 8000 volts for 32,000 V-h. Electrophoresis in the second dimension was performed on a 12% SDS-PAGE gel using a Bio-Rad Protean II apparatus. Gels were silver-stained (Amersham Biosciences), scanned, and analyzed using Imagemaster 2-D software, Version 2.0 (Amersham Biosciences). For mass spectrometry, axonemes were electrophoresed under identical conditions, except 120 µg of axonemes were loaded, and the gel was stained with Pro-Blue colloidal Coomassie stain (Owl Separation Systems, Portsmouth, NH) with omission of the first fixation step. Individual spots were excised, digested with trypsin as described previously (13), and analyzed by LC/MS/MS (see below).
1-D Gel and Analysis
Purified ciliary axonemes (50 µg/lane) were separated on a 16-cm pre-cast 816% SDS-PAGE gel (Bio-Rad) and stained with Pro-Blue. The gel was sliced into 46 individual bands, including one large band containing tubulin. Bands from two lanes were pooled, and in-gel digestion was performed as above.
Digestion of Axonemes for Direct Analysis
For direct analysis by LC/MS/MS, a 30-µg aliquot of purified ciliary axonemes was solubilized using 6 M guanidine HCl (pH 8.0). The solubilized axonemes were then loaded onto a reversed phase cartridge and digested in situ with endoprotease Lys-C (14). For direct analysis by LC/LC/MS/MS, a 30-µg aliquot was initially solubilized using 5 µl of hexafluoroacetone and enough 6 M urea to solubilize the pellet completely. The sample was diluted to 2 M urea with a 20 mM Tris buffer (pH 8.5) and digested in solution with endoprotease Lys-C. Lys-C was used for digestion, because it remains active in the solutions used.
Peptide Sequencing by Mass Spectrometry
In-gel and solution digests of ciliary axonemal proteins were analyzed by nanoscale capillary LC/MS/MS using an UltimateTM capillary LC system, Switchos valve switching unit, and Famos autosampler (LC Packings, San Francisco, CA) coupled to a quadrupole time-of-flight mass spectrometer (Q-TOF2; Micromass, Manchester, United Kingdom) as described previously (15). In addition to the LC/MS/MS analysis, a multidimensional LC/LC/MS/MS approach similar to that described by Yates and co-workers (9) was performed using strong cation exchange in the first LC dimension and reversed-phase in the second dimension. Peptides were sequentially step-eluted from the 300-µm inner diameter x 5-mm strong cation exchange column (LC Packings, San Francisco, CA) packed with polysulfoethyl aspartamide material (PolyLC, Columbia, MD) onto a reversed-phase trapping cartridge using a 5 mM KH2PO4 buffer (pH 3.0) containing 0, 25, 35, 50, 60, 75, 100, or 200 mM KCl. Peptides from each salt fraction were then analyzed by sequential reversed phase LC/MS/MS analyses. Following data acquisition, LC/LC/MS/MS datafiles from each salt step were processed initially using the Proteinlynx module of Masslynx 3.4 (Micromass) to generate Mascot-searchable *.pkl files. A peptide QA filter of 20 was used in Proteinlynx to eliminate poor quality spectra prior to database searching. This filter takes into account the presence of immonium ions, the intensity of the product ion peaks above precursor mass for multiply charged species, the base peak intensity, and amino acid mass differences between peaks. Proteinlynx-processed data (containing quality product ion spectra) from each salt step were then searched against an in-house nonredundant protein database using the Mascot program (16). Spectra with no matches from the protein database were subsequently searched against a database containing human expressed sequence tags (ESTs). Parameters used for all Mascot searches were as follows: allow up to one missed proteolytic cleavage; peptide mass tolerance, 2 Da; product ion mass tolerance, 0.3 Da. For samples analyzed from 1-D or 2-D gels, the following variable modifications were used in the searches: pyridylethyl-Cys, acrylamide-Cys, methionine oxidation. For samples analyzed from solution or in situ digests, only pyridylethyl-Cys was used as a variable modification. All peptide matches returned by Mascot with MOWSE scores above 12 were examined individually to assess the correctness of the match. Criteria that were used to accept matches include quality of the match (presence of an extended y- or b-ion series; sequence-specific fragmentation features such as unique immonium ions, preferential fragmentation at proline, etc.), as well as biological information about a particular protein that might point toward its presence in cilia. In many cases, a protein could be identified confidently on the basis of a single peptide match.
Western Blotting of Annexin/Sp17
Western blotting was performed as described previously (10) with the following modifications. Mouse monoclonal anti-annexin 1 (Biogenesis, Brentwood, NH) was used at 0.05 µg/ml. Rabbit anti-Sp17 was a generous gift from Dr. M. ORand and was used at a dilution of 1:5000. Membranes were blocked with 1% non-fat milk in Tris-buffered saline containing 0.05% Tween 20, and detection was with ECL reagents according to the manufacturer (Amersham Biosciences).
Immunostaining of Sections and Cultures
Paraffin sections of HBE cultures were immunostained with mouse anti-annexin 1 as described previously (10) using a concentration of 0.5 µg/ml. For immunolocalization of Sp17, cultures of well differentiated HBE cells were fixed in 4% paraformaldehyde, washed in phosphate-buffered saline, and permeabilized in 0.2% Triton X-100 for 15 min. Cultures were then incubated with affinity-purified anti-Sp17 (1:500) or with an equal concentration of rabbit antiserum depleted of Sp17-reacting antibodies by pre-absorption. Additional cultures were incubated with an identical concentration of normal rabbit IgG. Detection was performed using Texas Red-conjugated goat anti-rabbit and a Leica scanning confocal microscope.
RT-PCR of Retinitis Pigmentosa Protein RP1
Total RNA was isolated from cultures of HBE cells using an RNeasy kit (Qiagen), and RT-PCR was performed using the GeneAmp RNA PCR kit (Applied Biosystems, Branchburg, NJ), both according to the manufacturers instructions. Primers used were 5'-TGAAGGGCAGTCATTTGGCTCT-3' (forward) and 5'-AAGGGGTTGAGTCAGTTCCTCG-3' (reverse). Cycling conditions for amplification included an initial denaturation at 95 °C for 105 s, 4 cycles of 95 °C for 15 s; 60 °C for 30 s, 31 cycles of 95 °C for 15 s; 58 °C for 30 s, followed by a 1-min extension at 72 °C.
| RESULTS |
|---|
|
|
|---|
|
|
|
- and ß-tubulin spots, other known ciliary components identified by 2-D analysis included tektins (17), heat shock proteins (18, 19), and actin (20). Several proteins were considered potentially novel components of human cilia, including the AKAP-associated sperm protein, three mouse testis cDNAs, a testis-specific nucleoside diphosphate kinase, a c-Myc-binding protein found in sperm, and an EST from a human retinal library. Four of the remaining proteins are most likely contaminants, signal peptidase, endoplasmic reticulum ATPase, EIF-3B, and the phenylalanyl-tRNA synthetase. For the remaining 21 protein matches, there is insufficient information to determine whether they are associated with the ciliary axoneme or if they are cellular proteins that co-purify with the axoneme.
|
|
500 kDa). To obtain a more complete representation of the proteins comprising the human cilium, a preparation of purified axonemes was separated on a 1-D gradient gel (Fig. 3). The gel lanes were then sliced into 46 individual bands of a few mm each. Each of the bands was subjected to trypsin digestion, and the purified tryptic peptides were then sequenced by LC/MS/MS. This approach yielded sequence data on over 890 tryptic peptides that matched 195 protein entries and 148 ESTs. Combining redundant entries and removing several suspected contaminants (e.g. keratin, ribosomal proteins) resulted in a set of 123 possible axonemal proteins (Table II). Many ciliary proteins were detected that were not found in the 2-D PAGE experiment. For example, whereas no peptides were identified from DHCs in the 2-D gel, over 40 peptides were found to match DHC sequences in the 1-D experiment. Matches were found to dynein light and intermediate chains, as well. Many potentially novel ciliary components were also identified by this approach, including a brain-specific protein, a sperm surface protein, and the retinitis pigmentosa protein, RP1. Thirty-nine of the 123 matches were assigned to the known/likely axonemal group (Table III), whereas 17 were considered probable contaminants, leaving 67 proteins as potential newly identified axonemal proteins. Many of these matches were to predicted or hypothetical proteins and probably represent novel ciliary components. Many peptides that only matched ESTs were also identified (Supplemental Material contains a list of all ESTs identified in this study), and these may also represent novel axonemal components.
|
To increase the amount of sequence information obtained from a single sample, axonemal proteins were again digested with Lys-C but were subjected to an additional LC separation step before analysis by MS/MS. Peptide fragments were applied to a strong cation exchange resin and sequentially eluted with a series of increasing salt concentrations. The eluted peptides were further resolved on an in-line reverse phase column and then sequenced by nanoelectrospray MS/MS. This approach yielded sequence data on an additional 250 peptides. Matches were obtained to 84 separate entries in the databases, 30 of which were also found in the earlier studies, thereby confirming these results (Table II). Of the remaining 54 entries, 12 were added to the known/likely axonemal protein list (Table III), whereas six were considered likely contaminants. As in the above studies, the majority of the remaining 36 matches are to novel or hypothetical proteins, for which there is at present no evidence to determine whether they are axonemal proteins.
Combining the data from the four experiments described above results in peptide matches to over 210 proteins (Table II). As expected, matches were obtained to many known components of the axoneme, including
- and ß-tubulin, the light, intermediate, and heavy chains of axonemal dynein, and the radial spoke proteins (Table III). Others are most likely cellular contaminants that co-purify along with the axonemes, including ribosomal and nuclear proteins. Of greatest interest are the many proteins that have not been described previously as being part of the ciliary apparatus. To assess whether the above experiments had identified potentially novel components of human cilia, strategies were explored to test for the expression of selected proteins identified by MS/MS in cilia or ciliated cells.
In the analysis of ciliary proteins after 1-D gel electrophoresis, many peptides were obtained that matched the calcium-dependent phospholipid-binding proteins known as annexins. This is not surprising, because annexins can be precipitated by the concentrations of calcium used during the cilia isolation procedure (23), and this preparation of cilia was not washed extensively to remove ciliary membranes. To test whether annexin was present in the cilia preparations used for MS analysis, isolated axonemes were separated on an SDS-PAGE gel and transferred to nitrocellulose for Western blotting. Probing the membrane with a monoclonal antibody to annexin I resulted in a strong signal of the expected size, clearly demonstrating that annexin I was present in preparations of isolated cilia (Fig. 4A). Next, cultured HBE cells were immunostained with the anti-annexin I antibody to examine the cellular location of the protein. Cilia were clearly labeled by the anti-annexin 1 antibody (Fig. 4B), whereas cultures labeled with control mouse IgG showed little background staining. Interestingly, the nuclei of ciliated cells also stained positively for annexin I. A similar localization of annexin I has been previously reported in the rabbit trachea (23).
|
|
26-kDa protein that migrated with the same mobility as purified recombinant human Sp17 (Fig. 6A, lanes 2 and 4) whereas no signal in this region was detected in lysates from undifferentiated cultures (Fig. 6A, lane 1). To determine whether Sp17 was localized to the cilia of airway epithelial cells, isolated ciliary axonemes were probed by Western blotting (Fig. 6A, lane 3). A strong signal of the expected size was observed, as well as many higher molecular weight bands. These may be the result of Sp17 aggregation (recombinant human Sp17 is known to aggregate),2 or Sp17 may be bound tightly to other axonemal components. Finally, differentiated cultures of HBE cells were immunostained with the affinity-purified Sp17 antisera. Although the control pre-adsorbed serum showed no specific staining (Fig. 6B, right panel), the Sp17 antisera strongly labeled the cilia (Fig. 6B, left and center panels). These results clearly demonstrate that Sp17 is a component of human airway cilia, validating the result obtained by mass spectrometry.
|
| DISCUSSION |
|---|
|
|
|---|
It is clear from the studies reported here and elsewhere that the technique of 2-D gel electrophoresis followed by mass spectrometry to identify individual protein spots is useful but suffers from several limitations. A clear example from this study is the inability of 2-D gels to resolve the high molecular weight dynein heavy chains that are essential components of the ciliary apparatus. Although 1-D gels avoid some of the problems associated with 2-D gels, this approach is also very labor-intensive. In addition, most gel slices contained multiple proteins, and proteins of low abundance may be difficult to identify if they migrate similarly to a more abundant protein, such as tubulin. In contrast, digesting a sample of isolated axonemes in solution eliminates many of the variables and labor involved in gel electrophoresis. Further, the use of multidimensional liquid chromatography to resolve and concentrate the resulting peptide fragments allows for the efficient identification of the proteins present in the original mixture. However, each of the four approaches utilized in the current study identified peptides not identified by any of the other techniques. Similarly, very few of the proteins were identified by more than one approach. This is not surprising, because previous studies demonstrated that repeated analyzes of the same complex protein sample by LC/MS/MS resulted in different peptides being sequenced in each analyses (15). Some of the differences in the present study are also no doubt because of sample variation. However, it seems unlikely that a single approach will be able to resolve all the proteins present in a complex sample such as an axoneme. Therefore although it is useful to compare the results obtained by the different techniques, they can also be viewed as complementary approaches that can be combined to achieve better sample coverage.
The combination of these different approaches has resulted in significant progress toward obtaining a complete proteome of human ciliary axonemes. The only available estimate of the total number of proteins in an axoneme is from studies of Chlamydomonas. By analyzing isolated flagella using 2-D PAGE, Luck and co-workers (5, 6) estimated that an axoneme consists of
250 proteins. This number may represent a minimum value, because it is clear that 2-D PAGE does not resolve all proteins (e.g. DHCs), and multiple proteins may be present in a single spot. Alternatively, the total number of individual axonemal proteins may be <250, because the same protein may exist in multiple forms, and some of the proteins are cellular constituents that co-purify with the axoneme.
As a first step toward obtaining a human axonemal proteome, we have developed a 2-D map of isolated cilia that consists currently of over 240 well resolved components. This number is similar to the estimate of 250 proteins in a Chlamydomonas flagellum. Although this map does not include all axonemal components (see above), this map will be useful for the targeted identification of specific axonemal components, for example, proteins absent from the cilia of PCD patients. In-gel digestion of individual spots followed by LC/MS/MS allowed us to identify 38 proteins present throughout this map, which will provide useful landmarks for future experiments.
Second, by taking advantage of additional proteomic approaches, peptide sequences to other potential axonemal proteins were obtained. Separation of axonemal proteins on a 1-D gradient gel allowed us to identify proteins not resolved on the 2-D gels, including DHCs. By digesting axonemes directly in solution, we were able to omit the time-consuming gel electrophoresis and analysis steps. Analyzing these samples, by LC/MS/MS or LC/LC/MS/MS, generated additional data sets that contained proteins both unique and common to each of the other approaches. In total, peptide sequences were obtained to over 210 potential axonemal proteins. If an axoneme is assumed to be comprised of
250 proteins, this data set could represent
85% of the axonemal proteins. In addition, we obtained peptide matches to over 200 human ESTs. Although many of these may be redundant, it is likely that some of them represent additional novel axonemal proteins. Further characterization of these ESTs will therefore increase the percentage of axonemal proteins identified.
Sixty-five of the 214 matches (
30%) have been assigned as known or likely axonemal components based on literature or database annotations that are consistent with the protein having a potential axonemal location (Table III). These results confirm the presence of many proteins that are expected to be components of cilia, including
- and ß-tubulin, radial spoke proteins, and light, intermediate, and heavy chains of dynein. For example, many peptides were obtained that matched the sequence of human dynein heavy chain 9. This is not surprising, because this outer arm DHC has been completely sequenced from human. In contrast, two peptides were obtained that perfectly matched the sequence for sea urchin DHC isotype 3a, although showing significant homology to several DHCs from other species. Because there are at least 12 highly homologous axonemal DHCs, some with multiple isoforms, additional studies will be needed to identify the full-complement of human axonemal DHCs present in cilia. These data also demonstrate that when analyzing highly conserved families of proteins, which may have different splice variants, a single peptide sequence may not provide unambiguous identification.
Many proteins were identified that were not known previously to be components of airway cilia. For some of these, the available information about these proteins suggests that they are axonemal proteins. For example, several sperm- or testis-specific proteins were identified, including an AKAP-associated sperm protein (30), SPAG 6, and Sp17. SPAG6 demonstrates 85% similarity to the Chlamydomonas protein pf16, which localizes to the flagellar central pair microtubules (31), whereas Sp17 has been localized to both the acrosomal region and throughout the sperm tail. Proteins from other tissues that contain axonemal structures were also identified, including the retinitis pigmentosa protein, RP1, and a brain-specific protein. These data demonstrate the remarkable conservation of axonemal structure, even between diverse cellular tissues. In the future, a proteomic comparison of different axonemal structures will be useful to not only identify conserved proteins but to identify the unique proteins that are responsible for the specialized function of each particular axoneme.
The remaining proteins, which constitute the majority of proteins identified, are proteins for which there is insufficient information to determine whether they are axonemal components or cellular contaminants. Although the isolation procedure used results in a highly enriched preparation of ciliary axonemes, it is clear that other cellular structures were pelleted along with the axonemes during centrifugation. Therefore, it is not surprising that peptides were obtained from proteins known to be components of the nucleus and ribosome. However, the number of proteins identified in these studies known to be non-axonemal is low (
10%), suggesting that the majority of the proteins identified may be axonemal components.
Finally, to test whether that these experiments had in fact resulted in the identification of novel axonemal components, we explored several methods to test whether the proteins identified in the proteomic screen are associated with cilia or ciliated cells. In the case of previously characterized proteins for which antibodies are available (e.g. annexin 1, Sp17), Western blotting of isolated axonemes was used to demonstrate the presence of these proteins in the ciliary preparation. Immunostaining was also used to demonstrate that annexin 1 and Sp17 localized to the cilia in differentiated cultures of HBE cells. For unknown proteins or proteins for which antibodies are not available, RT-PCR can be used to determine whether the mRNA for the protein is expressed in ciliated cultures and also if the expression of the mRNA correlates with ciliogenesis. For example, the expression of retinitis pigmentosa protein RP1 mRNA was demonstrated clearly in ciliated HBE cells, and the level of RP1 expression appeared to correlate with ciliated cell differentiation. Thus selected proteins, identified as being components of ciliary axonemes by proteomic techniques, were confirmed by biochemical studies. Although each of the potentially novel axonemal components identified in this study will require similar verification, these data provide approaches to validate the results of the proteomic analysis.
In summary, we have used proteomic techniques to identify many potentially novel components of human cilia. Future studies will focus on optimization of these techniques to identify additional axonemal proteins. In addition, similar strategies will be applied to analyze both the ciliary membrane and the soluble matrix components. The results of these studies will lead to a greater understanding of cilia structure and regulation and will form a basis for investigating changes in the ciliary proteome in response to experimental variables. A complete ciliary proteome will also be invaluable for comparing cilia from normal and diseased specimens and for identifying proteins that are conserved/unique between axonemes from different tissues, e.g. airway cilia and sperm flagella.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Published, MCP Papers in Press, June 21, 2002, DOI 10.1074/mcp.M200037-MCP200
1 The abbreviations used are: PCD, primary ciliary dyskinesia; HBE, human bronchial epithelial; DHC, dynein heavy chain; LC/MS/MS, liquid chromatography-tandem mass spectrometry; LC/LC/MS/MS, two-dimensional liquid chromatography-tandem mass spectrometry; EST, expressed sequence tag; 2-D, two-dimensional; 1-D, one-dimensional. ![]()
2 M. ORand, personal communications. ![]()
* This research was supported in part by National Institutes of Health Grant HL63103 (to L. E. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ![]()
S The on-line version of this article (available at http://www.mcponline.org) contains Supplemental Material. ![]()
To whom correspondence should be addressed: The University of North Carolina at Chapel Hill, School of Medicine, Cystic Fibrosis/Pulmonary Research and Treatment Center, CB# 7248, 6123A Thurston-Bowles Bldg., Chapel Hill, NC 27599-7248. Tel.: 919-843-7177; Fax: 919-966-7524; ostro{at}med.unc.edu
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Kubo, A. Yuba-Kubo, S. Tsukita, S. Tsukita, and M. Amagai Sentan: A Novel Specific Component of the Apical Structure of Vertebrate Motile Cilia Mol. Biol. Cell, December 1, 2008; 19(12): 5338 - 5346. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chhin, J. T. Pham, L. El Zein, K. Kaiser, O. Merrot, and P. Bouvagnet Identification of transcripts overexpressed during airway epithelium differentiation Eur. Respir. J., July 1, 2008; 32(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Hoeng, S. C. Dawson, S. A. House, M. S. Sagolla, J. K. Pham, J. J. Mancuso, J. Lowe, and W. Z. Cande High-Resolution Crystal Structure and In Vivo Function of a Kinesin-2 Homologue in Giardia intestinalis Mol. Biol. Cell, July 1, 2008; 19(7): 3124 - 3137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Adams, U M Smith, C V Logan, and C A Johnson Recent advances in the molecular pathology, cell biology and genetics of ciliopathies J. Med. Genet., May 1, 2008; 45(5): 257 - 267. [Abstract] [Full Text] [PDF] |
||||